Previous 10 | Next 10 |
The entire world anxiously awaits good news in the race to develop a vaccine for novel coronavirus disease COVID-19 . And there are plenty of drugmakers hoping to be the bearers of some good news, including both big pharmaceutical companies and small biotechs. Some investors could be temp...
Any list of companies in the thick of the battle against novel coronavirus disease COVID-19 absolutely needs to include Johnson & Johnson (NYSE: JNJ) and Emergent BioSolutions (NYSE: EBS) . Johnson & Johnson is the largest healthcare company in the world with tremendou...
Biotech Pulse Source: COVID-19 image by Getty Images; edits by PrudentBiotech.com It has taken a pandemic for biotechs to take flight towards their all-time high. One of the first industry groups to recover from the virus-related selloff and be neutral for the year, biotech indexes hav...
GAITHERSBURG, Md., May 12, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences this month: BofA Securities 2020 Virtual Health Care ...
Mr. Rogers always related his mom's advice on how to find hope in times of crisis. "Look for the helpers," Nancy Rogers would say. "You will always find people who are helping." This isn't advice from a Wall Street wizard, but it does apply to the stock market in this time of pandemic....
The long-term solution to ending the coronavirus pandemic and returning to normal life is an effective vaccine. Companies and researchers across the globe have accepted the challenge of trying to develop one as quickly as possible. Investors expect the stocks of companies that successfully deliv...
The following slide deck was published by Emergent BioSolutions Inc. in conjunction with their 2020 Q1 earnings Read more ...
GAITHERSBURG, Md., May 07, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2020 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 21, 2020 at 9:00 AM EDT. The Company, which disclosed the mov...
Emergent BioSolutions, Inc. (EBS) Q1 2020 Results Conference Call April 30, 2020 5:00 PM ET Company Participants Bob Burrows - VP, IR Bob Kramer - President and Chief Executive Officer Rich Lindahl - Chief Financial Officer Syed Husain - Senior Vice President and Head of CDMO B...
Image source: The Motley Fool. Emergent BioSolutions Inc (NYSE: EBS) Q1 2020 Earnings Call Apr 30, 2020 , 5:00 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...